Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    15315996 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Radiation: IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE;   Radiation: Proton (prostate bed) to 70.2 CGE;   Radiation: IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE;   Radiation: Proton to 66.6 CGE
2 Active, not recruiting Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN
3 Active, not recruiting Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Flutamide (Eulexin) and  Lupron or Zoladex;   Radiation: External Beam Radiotherapy
4 Completed Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial
Condition: Prostate Cancer
Interventions: Radiation: External beam radiation;   Drug: Lupron;   Drug: Casodex

Indicates status has not been verified in more than two years